The risk of fungal infection is a serious problem for very ill persons, especially for hematological patients and patients in ICU because of their immune depression and the high administration of antimicrobial drugs, which tends to increase the number of fungae in the body. Professor Andrea Novelli speaks about the available drugs against fungal infections, focusing on both their pharmacokinetic and pharmacodynamic properties.